These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9410899)

  • 41. Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats.
    David A; Chétritt J; Guillot C; Tesson L; Heslan JM; Cuturi MC; Soulillou JP; Anegon I
    Gene Ther; 2000 Mar; 7(6):505-10. PubMed ID: 10757024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
    Song K; Chang Y; Prud'homme GJ
    Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful DNA transfer in cultured human mesangial cells using replication deficient recombinant adenovirus.
    Nahman NS; Clark KR; Sferra TJ; Urban KE; Troike AE; Kronenberger J; Sedmak DD
    J Investig Med; 1998 Jun; 46(5):204-9. PubMed ID: 9676052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrauterine gene transfer: gestational stage-specific gene delivery in mice.
    Türkay A; Saunders T; Kurachi K
    Gene Ther; 1999 Oct; 6(10):1685-94. PubMed ID: 10516717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-tumor immunity against CT26 colon tumor in mice immunized with plasmid DNA encoding beta-galactosidase fused to an envelope protein of endogenous retrovirus.
    Takeda J; Sato Y; Kiyosawa H; Mori T; Yokoya S; Irisawa A; Miyata M; Obara K; Fujita T; Suzuki T; Kasukawa R; Wanaka A
    Cell Immunol; 2000 Aug; 204(1):11-8. PubMed ID: 11006013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
    Mitchell M; Jerebtsova M; Batshaw ML; Newman K; Ye X
    Gene Ther; 2000 Dec; 7(23):1986-92. PubMed ID: 11175309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
    Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
    Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
    Ye X; Robinson MB; Pabin C; Batshaw ML; Wilson JM
    Gene Ther; 2000 Oct; 7(20):1761-7. PubMed ID: 11083498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
    Yoon SK; Armentano D; Wands JR; Mohr L
    Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12.
    Gambotto A; Tüting T; McVey DL; Kovesdi I; Tahara H; Lotze MT; Robbins PD
    Cancer Gene Ther; 1999; 6(1):45-53. PubMed ID: 10078963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients.
    Tursz T; Cesne AL; Baldeyrou P; Gautier E; Opolon P; Schatz C; Pavirani A; Courtney M; Lamy D; Ragot T; Saulnier P; Andremont A; Monier R; Perricaudet M; Le Chevalier T
    J Natl Cancer Inst; 1996 Dec; 88(24):1857-63. PubMed ID: 8961977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamics of gene transfer to retinal pigment epithelium.
    da Cruz L; Rakoczy P; Perricaudet M; Constable IJ
    Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2447-54. PubMed ID: 8933761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors.
    Zepeda M; Wilson JM
    Gene Ther; 1996 Nov; 3(11):973-9. PubMed ID: 8940637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High levels of gene transduction in human lung tumors following intralesional injection of recombinant adenovirus.
    Cusack JC; Spitz FR; Nguyen D; Zhang WW; Cristiano RJ; Roth JA
    Cancer Gene Ther; 1996; 3(4):245-9. PubMed ID: 8853549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.
    Croyle MA; Chirmule N; Zhang Y; Wilson JM
    J Virol; 2001 May; 75(10):4792-801. PubMed ID: 11312351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.
    Ilan Y; Prakash R; Davidson A; Jona ; Droguett G; Horwitz MS; Chowdhury NR; Chowdhury JR
    J Clin Invest; 1997 Mar; 99(5):1098-106. PubMed ID: 9062369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung.
    Minter RM; Rectenwald JE; Fukuzuka K; Tannahill CL; La Face D; Tsai V; Ahmed I; Hutchins E; Moyer R; Copeland EM; Moldawer LL
    J Immunol; 2000 Jan; 164(1):443-51. PubMed ID: 10605041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung.
    Kaplan JM; Armentano D; Sparer TE; Wynn SG; Peterson PA; Wadsworth SC; Couture KK; Pennington SE; St George JA; Gooding LR; Smith AE
    Hum Gene Ther; 1997 Jan; 8(1):45-56. PubMed ID: 8989994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BAPS Prize--1997. Fetal gene therapy: efficacy, toxicity, and immunologic effects of early gestation recombinant adenovirus. British Association of Paediatric Surgeons.
    Yang EY; Cass DL; Sylvester KG; Wilson JM; Adzick NS
    J Pediatr Surg; 1999 Feb; 34(2):235-41. PubMed ID: 10052795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.